The Rise of Modular Reagent Manufacturing — Scalable Solutions to Accelerate Novel Gene Therapy Development
Time: 10:15 am
day: Conference Day One
Details:
Novel gene therapy development is focused on increasingly individualized and diverse solutions, requiring smaller, more customized batches of reagents and buffers to be used across the clinical pipeline as companies scale from research to process development and into commercialization. Existing bioprocessing infrastructure was not designed to manufacture these new therapies, forcing the industry to look for research and clinical-grade reagent formulations that are easily customizable, scalable, and efficiently produced. Find out more about what criteria novel therapy developers should be considering when evaluating reagent solutions.
